What is the appropriate management of peri‑ungual eczema (eczema affecting the nail folds) in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Periungual Eczema in Adults

For periungual eczema affecting the nail folds, apply a mid-to-high potency topical corticosteroid ointment to the nail folds twice daily, combined with gentle skin care and daily emollient application to the cuticles and periungual tissues. 1, 2, 3

Initial Assessment and Diagnosis

Before initiating treatment, examine for:

  • Extent and severity of periungual inflammation - look for erythema, edema, and scaling of the nail folds 1
  • Signs of secondary infection - crusting, weeping, purulent discharge, or warmth suggest bacterial superinfection 1, 2
  • Nail plate involvement - check for pitting, ridging, or onycholysis that may indicate psoriasis rather than eczema 1
  • Aggravating factors - exposure to irritants (soaps, detergents, water), occupational exposures 1

Treatment Algorithm

First-Line Therapy (Mild Periungual Eczema)

Topical corticosteroids:

  • Apply mid-to-high potency topical corticosteroid ointment (such as triamcinolone 0.1% or betamethasone valerate 0.1%) to affected nail folds twice daily 1, 2, 4
  • Potent and moderate topical corticosteroids are significantly more effective than mild corticosteroids for eczema treatment 4, 5
  • Once-daily application is as effective as twice-daily for potent corticosteroids, but twice-daily may be preferred initially for moderate-potency agents 4

Adjunctive measures:

  • Daily emollient application to cuticles and periungual tissues to restore the skin barrier 1, 2, 3
  • Use a dispersible cream as soap substitute rather than traditional soaps that strip natural lipids 1
  • Avoid irritants - wear gloves during cleaning, avoid excessive water exposure 1, 3, 6
  • Keep nails short but not too short, trim straight across 1, 3, 6

If Infection is Suspected

Do not use topical corticosteroids if purulent drainage is present until infection is adequately treated 1, 2

For suspected bacterial infection:

  • Obtain bacterial/viral/fungal cultures before starting antibiotics 1, 2, 3
  • Add topical povidone-iodine 2% twice daily as first-line antiseptic 1, 2, 3
  • Consider dilute vinegar soaks (50:50 dilution) for 10-15 minutes twice daily 1, 2
  • If moderate infection with systemic signs, add oral antibiotics (cephalexin or amoxicillin-clavulanate) 3, 6
  • Up to 25% of periungual inflammatory conditions have secondary bacterial or fungal superinfection 1, 3, 6

Reassessment and Escalation

Reassess after 2 weeks of treatment 1, 2, 3:

  • If improved, continue treatment and consider tapering to intermittent maintenance (twice weekly application) to prevent relapse 4, 7
  • Weekend (proactive) therapy with topical corticosteroids reduces relapse likelihood from 58% to 25% 4
  • If no improvement or worsening, consider:
    • Increasing corticosteroid potency (e.g., from moderate to potent) 4, 5
    • Intralesional triamcinolone acetonide 5-10 mg/cc for refractory cases involving nail matrix 1
    • Referral to dermatology for alternative diagnoses or advanced therapies 6

Important Clinical Considerations

Corticosteroid Potency Selection

  • Potent corticosteroids (betamethasone dipropionate 0.05%, mometasone furoate 0.1%) are more effective than moderate-potency agents for moderate-to-severe eczema 4, 5
  • Very potent corticosteroids (clobetasol propionate 0.05%) show uncertain additional benefit over potent corticosteroids for short-term use 4
  • The periungual area has relatively thick skin, making moderate-to-potent corticosteroids appropriate 5

Safety Profile

  • Short-term use (median 3 weeks) of potent topical corticosteroids shows no evidence of increased skin thinning 5
  • Abnormal skin thinning occurred in only 1% of participants across trials, with most cases from very potent corticosteroids 4
  • Application-site reactions are least likely with topical corticosteroids compared to calcineurin inhibitors 5

Common Pitfalls to Avoid

  • Undertreatment due to steroid phobia - explain that appropriate short-term use of potent corticosteroids is safe and effective 1, 4
  • Using topical steroids on infected eczema - always treat infection first or concurrently 1, 2
  • Inadequate emollient use - emollients are essential adjuncts, not optional 1
  • Cutting nails too short - this can cause trauma and worsen periungual inflammation 3, 6

Alternative Diagnoses to Consider

If treatment fails after 2-4 weeks, reconsider the diagnosis:

  • Psoriasis - look for nail pitting, salmon patches, or psoriatic plaques elsewhere 1
  • Contact dermatitis - consider patch testing for occupational or cosmetic allergens 1
  • Chronic paronychia - may require different management with antifungals if Candida is involved 3, 6

Maintenance Therapy

Once remission is achieved:

  • Transition to intermittent application (2 applications per week, typically on weekends) to maintain remission 4, 7
  • Continue daily emollient application indefinitely 1
  • Avoid known triggers and maintain protective measures (gloves, gentle cleansers) 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Paronychia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Paronychia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Research

Topical anti-inflammatory treatments for eczema: network meta-analysis.

The Cochrane database of systematic reviews, 2024

Guideline

Treatment of Acute Paronychia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What treatment options are available for a patient with eczema who is unresponsive to triamcinolone (corticosteroid) cream?
What is the preferred treatment for a patient with moderate to severe eczema, comparing clobetasol (clobetasol propionate) vs triamcinolone (triamcinolone acetonide)?
What are the best topical treatments for a severe eczema flare?
What is the best initial treatment for a patient with eczema exacerbated by cold weather?
What treatment is recommended for a patient with an eczema flare-up who has previously responded well to Clobetasol (clobetasol propionate)?
In an adult patient presenting in coma after vomiting and diarrhea with severe hypertension (200/100 mm Hg), atrial fibrillation with a normal ventricular response, fever 39 °C, oxygen saturation 83 % on room air, normal respiratory rate, and normal glucose, what is the immediate management?
How should a 34-year-old woman with diabetes and a glycated hemoglobin (A1C) of 6.5% who is planning pregnancy be managed pre-conception?
What home care and warning signs should I advise parents for a pediatric laceration sustained last night?
What is plantar fasciitis?
In a 22-year-old male with schizoaffective disorder, bipolar type, currently in a mixed episode with visual hallucinations who develops intolerable akathisia on day 3 of cariprazine (Vraylar) 1.5 mg daily, what is the best immediate intervention?
Is it safe to combine buspirone, duloxetine, and bupropion in an adult patient, and what monitoring is needed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.